Showing results (1581-1590 of 1,608) with videos related to
Sort By:
Pageof 161
Journal of Neurogastroenterology and Motility|November 20, 2025
Bali Chronic Constipation Roundtable Report: Chronic Constipation Management in AsiaYi Ping Ren, Wah Loong Chan, Kee Huat Chuah, et al.Pharmacogenomics|July 18, 2013
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactionsHsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, et al.Lancet (London, England)|April 2, 2025
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trialXinyang Hu, Jinlong Zhang, Seokhun Yang, et al.Circulation. Cardiovascular Interventions|May 19, 2026
Angiography-Derived FFR versus IVUS to Guide PCI According to Angiographic Lesion CharacteristicsSeokhun Yang, Xinyang Hu, Jinlong Zhang, et al.Orthopaedic Journal of Sports Medicine|October 29, 2019
Chinese Consensus on Insertional Achilles Tendinopathy, Hanlin Xu, Hongyun Li, et al.Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.International Journal of Antimicrobial Agents|June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.International Journal of Antimicrobial Agents|June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 5, 2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, et al.Pageof 161